Sponsor pipeline

Gradient Denervation Technologies clinical trial pipeline

Get alerts when Gradient Denervation Technologies's trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-10-20

What changed in the last 30 days

1 trial changed in the last 30 days: 0 stopped, 0 with notable changes, 1 with a minor change only.

  1. Minor

    PreVail-PH2 · Pulmonary Artery DenerVation Clinical Study Using the Gradient Denervation System in Heart Failure · Pulmonary Hypertension Group 2 (PreVail-PH2 Study)

    Primary completion pushed from Dec 2026 to Jun 2027

    Also in this update: Study completion pushed from Jul 1, 2028 to Jun 1, 2030

    Gradient Denervation TechnologiesNot applicable NCT06052072 Registry history of NCT06052072 on ClinicalTrials.gov (opens the registry)

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.

Active trials by phase

Not charted: 3 active trials with no phase listed on ClinicalTrials.gov (typically behavioural, device, procedure and observational studies).

Disease areas by active trials

Get alerts when Gradient Denervation Technologies's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free